Product Identification


Neurontin^®, also known by its generic name, or gabapentin (generic) is a prescription drug manufactured by Pfizer, Inc. The Plaintiffs in this lawsuit claim that the manufacturers of Neurontin fraudulently promoted its use to treat conditions for which it was not approved by the FDA.

Below are the FDA-approved uses of Neurontin and a sampling of conditions for which Neurontin may have been prescribed, but are not approved by the FDA.

FDA-approved uses
Neurontin is FDA-approved as adjunctive therapy (added to other antiepileptic drugs) for partial seizures in adults and children.

Neurontin is also FDA-approved for the management of postherpetic neuralgia ("PHN"). PHN is the pain that lasts one to three months after shingles has headled.

The full FDA-approved product information is available at the link below:

• Neurontin Product Information-PDF
  

Uses not approved by the FDA
Neurontin has not been approved by the FDA to treat the following conditions, among others:

• Bipolar disorder
  
• Migraine headaches
  
• Pain management
  
• Arthritis
  
• Depression, Anxiety disorder, Social phobias
  
• Restless Leg Syndrome
  
• ADD/ADHD
  
• Mono-therapy for partial epileptic seizures (that is, treatment for partial seizures with Neurontin alone)
  

Adobe Acrobat Reader is required to view this document. If you do not have Adobe Acrobat, please click here.

---